NCT01895179

Brief Summary

The purpose of this pilot study is to find out what eating meals in a short time period early in the day (time-restricted feeding) versus eating meals spread out during the day (grazing) does to the body's ability to control blood sugar and to the health of its blood vessels. The investigators hypothesize that time-restricted feeding will be more effective at improving glucose tolerance and vascular condition (inflammation and micro- and macro-vascular function) than grazing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 3, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 10, 2013

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

March 16, 2018

Status Verified

March 1, 2018

Enrollment Period

4.3 years

First QC Date

July 3, 2013

Last Update Submit

March 15, 2018

Conditions

Keywords

Time-restricted feedingIntermittent fastingPrediabetesInsulin resistanceGlucose toleranceInsulin sensitivityCircadian rhythmsDiurnal

Outcome Measures

Primary Outcomes (1)

  • Change in Glucose Tolerance

    Glucose tolerance and indices of glucose homeostasis will be determined using an Oral Glucose Tolerance Test (OGTT).

    Before and after 5 weeks on each feeding schedule

Secondary Outcomes (2)

  • Change in Vascular Function

    Before and after 5 weeks on each feeding schedule

  • Change in Inflammation and Metabolic Markers

    Before and after 5 weeks on each feeding schedule

Study Arms (2)

Time-Restricted Feeding (early in the day eating)

EXPERIMENTAL

Participants will consume all meals early in the day and within a 6-hour window.

Other: Time-Restricted Feeding

Grazing

PLACEBO COMPARATOR

Participants will eat meals spread out over the course of the day.

Other: Grazing

Interventions

Time-restricted feeding is a variant of intermittent fasting that involves eating all of one's calories within a few hours each day (typically 4-9 hours), followed by a daily fast of 15-20 hours.

Time-Restricted Feeding (early in the day eating)
GrazingOTHER

Grazing involves eating meals spread out over the course of the day.

Grazing

Eligibility Criteria

Age35 Years - 70 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Are male
  • Overweight: Have a body mass index between 25 and 50 kg/m\^2 inclusive (a number calculated from height and weight)
  • Are 35-70 years of age
  • Have a hemoglobin A1C between 5.5 - 6.4% or prior medical indication of prediabetes
  • Have a blood sugar level between 140 and 199 mg/dL two hours after drinking a sugary solution (OGTT)
  • Have been eating dinner at least 8.5 hours after eating breakfast at least 90% of the time during the past year
  • Have not fasted (go for a day without any food) more than 12 days total during the past year
  • Be willing to eat most meals at Pennington Biomedical and/or under supervision
  • Not eat any food other than that served by Pennington Biomedical
  • Not drink any alcohol, juice, or other beverages that have calories other than what is served by Pennington Biomedical
  • Keep water and no-calorie drinks like tea or diet soda the same during both of the timed eating periods
  • Be willing to eat your meals according to the fixed schedules

You may not qualify if:

  • Have diabetes or are on anti-diabetes medication
  • Have evidence of cardiovascular disease
  • Suffer from significant cardiovascular, renal (kidney), cardiac (heart), liver, lung or nervous system disease
  • Evidence of significant gastrointestinal issues or surgery that impacts nutrient absorption
  • Regularly use medications such as steroids, beta blockers, and adrenergic-stimulating agents
  • Are on any regular medicine that has not had the same dose for 1 month or longer
  • Have a clinically significant abnormality as measured by a blood test
  • Regularly drink alcohol (more than 2 servings per day)
  • Have to do any kind of heavy physical activity
  • Currently perform overnight shift work more than one day a week
  • Are not able to eat only the food served to you by Pennington Biomedical, while in the study
  • Are not able to stop drinking alcohol or other drinks with calories (e.g., soda, juice) other than what is served to you by Pennington Biomedical, while in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

Location

Related Publications (1)

  • Allaf M, Elghazaly H, Mohamed OG, Fareen MFK, Zaman S, Salmasi AM, Tsilidis K, Dehghan A. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013496. doi: 10.1002/14651858.CD013496.pub2.

MeSH Terms

Conditions

Prediabetic StateInsulin ResistanceVascular DiseasesIntermittent Fasting

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperinsulinismCardiovascular DiseasesFastingFeeding BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor

Study Record Dates

First Submitted

July 3, 2013

First Posted

July 10, 2013

Study Start

July 1, 2013

Primary Completion

November 1, 2017

Study Completion

November 1, 2017

Last Updated

March 16, 2018

Record last verified: 2018-03

Locations